Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > JV vs Buyout

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Jan 31, 2023 7:15pm

170 Views

Post# 35258231

RE:RE:RE:JV vs Buyout

I tend to agree with ggrellette...the clause in often referred to as 'most favored nations clause' which gives the right to match any offer.

plantrader wrote: @ggrel, Thanks for the info. Sounds like that means a JV with one big pharma doesn't usually prevent other big pharma from being able to make a buyout offer. That's mainly what I was wondering about. Good to know.

ggrellette wrote: When a JV occurs there are conditions in the agreement. The JV partner will have to right to match any offers should a buyout be offered. This would certainly be one of the conditions.